Cutaneous squamous cell carcinoma (CSCC) is the second most frequent cancer in humans
and its incidence continues to rise. Although CSCC usually display a benign clinical …

Cutaneous squamous cell carcinoma (cSCC) is the second most common cancer, with its
incidence rising steeply. Immunosuppression is a well-established risk factor for cSCC, and …

Simple Summary Cutaneous squamous cell carcinoma (cSCC) is an increasingly prevalent
and morbid cancer worldwide. Management of this cancer has changed significantly in the …

Human malignancies arise predominantly in tissues of epithelial origin, where the stepwise
transformation from healthy epithelium to premalignant dysplasia to invasive neoplasia …

Non-melanoma skin cancers are cutaneous malignancies representing the most common
form of cancer in the United States. They are comprised predominantly of basal cell …

Background Immunotherapy has revolutionised the treatment of advanced cutaneous
squamous cell carcinoma (cSCC). It is important to understand both safety and efficacy in a …

Cutaneous squamous cell carcinoma (cSCC) represents 20% of all skin cancers. Although
primary cSCC s can be successfully treated with surgery, a subset of highly aggressive …

Cutaneous squamous cell carcinoma (cSCC), a non-melanoma skin cancer, is a
keratinocyte carcinoma representing one of the most common cancers with an increasing …

The advent of immune checkpoint inhibition represents a paradigm shift in the treatment of
an increasing number of cancers. However, the incredible therapeutic promise of …

Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer. In
immunosuppressed populations it is a source of considerable morbidity and mortality due to …